Toronto, Ontario (December 4, 2020) – Further to its news releases dated March 26, April 4, and July 2, 2019, Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products is pleased to announce that the Company has completed the acquisition of BBV Labs Inc. (“BBV”), a corporation formed under the laws of the Republic of Panama, pursuant to the previously announced share purchase agreement (the “Purchase Agreement”). 

See more